| Product NDC: | 0078-0459 |
| Proprietary Name: | Lopressor |
| Non Proprietary Name: | metoprolol tartrate |
| Active Ingredient(s): | 100 mg/1 & nbsp; metoprolol tartrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0078-0459 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017963 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19780115 |
| Package NDC: | 0078-0459-05 |
| Package Description: | 100 TABLET in 1 BOTTLE (0078-0459-05) |
| NDC Code | 0078-0459-05 |
| Proprietary Name | Lopressor |
| Package Description | 100 TABLET in 1 BOTTLE (0078-0459-05) |
| Product NDC | 0078-0459 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | metoprolol tartrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19780115 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | METOPROLOL TARTRATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |